Literature DB >> 617801

Leukocyte chemotaxis: a new in vivo testing technique.

A Otani, T E Hugli.   

Abstract

A new and sensitive technique is introduced for evaluating in vivo leukocyte chemotaxis. A small, disposable plastic chamber is used for holding the test solution, and an electric ink eraser for controlled abrasion of the skin test site. Another innovation is the use of capturing micropore membranes that, when placed between the test solution and the skin, collect cells for a permanent record. The small size of the chamber, the ease of application and immobilization, and the short time needed for cell collection permit experimentation with laboratory animals as well as with human volunteers. The accumulation of leukocytes in the chambers containing previously frozen or complement-activated autologous serum was 20 to 40-fold greater than in buffer controls after 3 h. Cell counts of approximately (1--2) x 10(3) leukocytes per mm3 were obtained in 3 h when serum diluted 1:1 with Hank's solution was applied to human or rabbit skin. Although predominantly polymorphonuclear leukocytes were detected in the chambers after just 3 h, prolonged incubations of 6--12 h found mononuclear cells also invading the chambers. These results clearly simulate the sequences of cellular emigration commonly observed in local inflammation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 617801     DOI: 10.1007/bf00920876

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  Leukocyte migration in vivo: a new method of study.

Authors:  M F Mass; P B Dean; W L Weston; J R Humbert
Journal:  J Lab Clin Med       Date:  1975-12

2.  Kinetic and comparative studies on localized leukocyte mobilization in normal man.

Authors:  H Senn; J F Holland; T Banerjee
Journal:  J Lab Clin Med       Date:  1969-11

3.  A quantitative Rebuck technic.

Authors:  C M Southam; A G Levin
Journal:  Blood       Date:  1966-05       Impact factor: 22.113

4.  A neutrophil chemotactic factor from human C'5.

Authors:  P A Ward; L J Newman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

5.  A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood.

Authors:  J Baum; A G Mowat; J A Kirk
Journal:  J Lab Clin Med       Date:  1971-03

6.  Effect of structural alterations on the photosensitizing potency of furocoumarins (psoralens) and related compounds.

Authors:  M A Pathak; L R Worden; K D Kaufman
Journal:  J Invest Dermatol       Date:  1967-02       Impact factor: 8.551

7.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

8.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

9.  The in vitro action of hydrocortisone on leucocyte migration.

Authors:  M M KETCHEL; C B FAVOUR; S H STURGIS
Journal:  J Exp Med       Date:  1958-02-01       Impact factor: 14.307

10.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  3 in total

1.  Microvascular function in skin windows.

Authors:  D M Humphrey; C Cavanaugh
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

2.  Ischemia activates neutrophils but inhibits their local and remote diapedesis.

Authors:  G Goldman; R Welbourn; J M Klausner; I S Paterson; L Kobzik; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

3.  Balanophora spicata and Lupeol Acetate Possess Antinociceptive and Anti-Inflammatory Activities In Vivo and In Vitro.

Authors:  Yuh-Fung Chen; Chien Ching; Tian-Shung Wu; Chi-Rei Wu; Wen-Tsong Hsieh; Huei-Yann Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-11       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.